Martin Joseph Cummins,Chau-Ting Yeh,Ching-Yuan Lee
申请号：
US15668001
公开号：
US09839672B1
申请日:
2017.08.03
申请国别(地区):
US
年份:
2017
代理人:
摘要：
An interferon composition is provided for enhancing the platelet count, reducing the recurrence rate of hepatitis, and/or improving the social function of hepatitis patients. The method comprises administering a low dose of IFN (about 5 IU to about 2500 IU of IFN-alpha) to a patient in need thereof. In one embodiment the IFN is alpha IFN or beta IFN, and more particularly, in one embodiment the administered biologically active IFN is human alpha IFN.
